To analyze the integrity of the drug during its release process, drug sample without any treatment and drug sample that was applied 8 V for 1 min were dissolved in D2O (151882, Merck KGaA, Germany). Extracts that were not dissolved in D2O were collected and dissolved in CDCl3 (151823, Merck KGaA, Germany). The samples were analyzed with 500-MHz NMR (Avance III-500, Bruker, Germany) installed at the National Center for Inter-university Research Facilities (NCIRF) at Seoul National University.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.